Leading UK Pharmacies trust Deltera
Protect against 9 types of Human Papillomavirus linked to various cancers. This PGD covers boys, girls, and adults, with Deltera managing the varied 1, 2, or 3-dose schedules based on patient age and history.
A Fully Digital Clinical Platform
Integrated Bookings and Payments
Secure & Connected Patient Records
Ditch the paperwork with secure digital records. Deltera automatically shares treatment summaries with the patient’s and sends the required notification to their GP instantly.
Training and Eligibility Requirements
To ensure clinical safety and regulatory compliance, all practitioners using this PGD must meet the following professional standards:
- Professional Registration: Must be a registered healthcare professional (e.g., Pharmacist) with a valid GPhC or PSNI registration and personal professional indemnity insurance.
- Clinical Competency: Practitioners must be self-certified as competent in the specific clinical area covered by this PGD and stay up to date with relevant national guidelines (e.g., The Green Book or NICE clinical summaries).
- Mandatory Training: Current certification in Basic Life Support (BLS) and the management of anaphylaxis is required for all injectable services.
- PGD Authorisation: The practitioner must have read and signed the PGD document within the Deltera Clinical Dashboard, with the authorisation counter-signed by the designated organisational lead or Superintendent.
- Premises Standards: Services must be conducted in a private consultation room that meets national standards for patient confidentiality and clinical safety.
Speak to the clinicians behind the platform
We understand the complexities of PGDs and clinical governance in the UK. Schedule a meeting with our team to see how we can help you navigate the changing landscape of community pharmacy.
Access related PGDs
FAQs
Anyone aged 9 to 45 who is not eligible via the NHS school programme. Deltera’s pre-screen helps identify the correct schedule—typically 1 dose for under-25s and 2 doses for those older.
Gardasil 9 protects against the nine most high-risk types linked to cervical, anal, and throat cancers. Deltera’s portal provides the patient with detailed advice on what the vaccine covers.
Yes. The PGD is universal. Deltera’s logic ensures that regardless of gender, the correct clinical assessment is performed and recorded for the patient's digital health history.
Yes. To ensure the national record is updated, Deltera automatically sends the vaccination details to the GP, ensuring integrated care and professional clinical compliance.
Still have questions?
Our team are here to support you.
Discover Deltera Practice Management
Deltera Practice Management digitalises your private pharmacy services, providing the complete pharmacy software package to offer a full range of Patient Group Directions (PGDs). Gain the oversight and efficiency you need to thrive.
